Literature DB >> 16507898

CD163 identifies perivascular macrophages in normal and viral encephalitic brains and potential precursors to perivascular macrophages in blood.

Woong-Ki Kim1, Xavier Alvarez, Jeanne Fisher, Benjamin Bronfin, Susan Westmoreland, JoAnne McLaurin, Kenneth Williams.   

Abstract

Perivascular macrophages are uniquely situated at the intersection between the nervous and immune systems. Although combined myeloid marker detection differentiates perivascular from resident brain macrophages (parenchymal microglia), no single marker distinguishes perivascular macrophages in humans and mice. Here, we present the macrophage scavenger receptor CD163 as a marker for perivascular macrophages in humans, monkeys, and mice. CD163 was primarily confined to perivascular macrophages and populations of meningeal and choroid plexus macrophages in normal brains and in brains of humans and monkeys with human immunodeficiency virus or simian immunodeficiency virus (SIV) encephalitis. Scattered microglia in SIV encephalitis lesions and multinucleated giant cells were also CD163 positive. Consistent with prior findings that perivascular macrophages are primary targets of human immunodeficiency virus and SIV, all SIV-infected cells in the brain were CD163 positive. Using fluorescent dyes that definitively and selectively label perivascular macrophages in vivo, we confirmed that dye-labeled simian perivascular macrophages were CD163 positive and able to repopulate the central nervous system within 24 hours. Flow cytometric studies demonstrated a subset of monocytes (CD163(+)CD14(+)CD16(+)) that were immunophenotypically similar to brain perivascular macrophages. These findings recognize CD163(+) blood monocytes/macrophages as a source of brain perivascular macrophages and underscore the utility of this molecule in studying the biology of perivascular macrophages and their precursors in humans, monkeys, and mice.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16507898      PMCID: PMC1606539          DOI: 10.2353/ajpath.2006.050215

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  77 in total

1.  Soluble CD163: a marker molecule for monocyte/macrophage activity in disease.

Authors:  H J Møller; H Aerts; H Grønbaek; N A Peterslund; P Hyltoft Petersen; N Hornung; L Rejnmark; E Jabbarpour; S K Moestrup
Journal:  Scand J Clin Lab Invest Suppl       Date:  2002

2.  Macrophage/microglial accumulation and proliferating cell nuclear antigen expression in the central nervous system in human immunodeficiency virus encephalopathy.

Authors:  Tracy Fischer-Smith; Sidney Croul; Aderonke Adeniyi; Katarzyna Rybicka; Susan Morgello; Kamel Khalili; Jay Rappaport
Journal:  Am J Pathol       Date:  2004-06       Impact factor: 4.307

3.  Human brain parenchymal microglia express CD14 and CD45 and are productively infected by HIV-1 in HIV-1 encephalitis.

Authors:  Melissa A Cosenza; Meng-Liang Zhao; Qiusheng Si; Sunhee C Lee
Journal:  Brain Pathol       Date:  2002-10       Impact factor: 6.508

4.  Proliferating cellular nuclear antigen expression as a marker of perivascular macrophages in simian immunodeficiency virus encephalitis.

Authors:  Kenneth Williams; Annette Schwartz; Sarah Corey; Marlene Orandle; William Kennedy; Brendon Thompson; Xavier Alvarez; Charlie Brown; Suzanne Gartner; Andrew Lackner
Journal:  Am J Pathol       Date:  2002-08       Impact factor: 4.307

5.  Bone marrow-derived cells that populate the adult mouse brain preserve their hematopoietic identity.

Authors:  Luc Vallières; Paul E Sawchenko
Journal:  J Neurosci       Date:  2003-06-15       Impact factor: 6.167

Review 6.  Monocyte/macrophage traffic in HIV and SIV encephalitis.

Authors:  Woong-Ki Kim; Sarah Corey; Xavier Alvarez; Kenneth Williams
Journal:  J Leukoc Biol       Date:  2003-08-11       Impact factor: 4.962

7.  Blood monocytes consist of two principal subsets with distinct migratory properties.

Authors:  Frederic Geissmann; Steffen Jung; Dan R Littman
Journal:  Immunity       Date:  2003-07       Impact factor: 31.745

8.  Distinct brain vascular cell types manifest inducible cyclooxygenase expression as a function of the strength and nature of immune insults.

Authors:  Jennifer C Schiltz; Paul E Sawchenko
Journal:  J Neurosci       Date:  2002-07-01       Impact factor: 6.167

9.  Induction of pathogenic sets of genes in macrophages and neurons in NeuroAIDS.

Authors:  Eleanor S Roberts; Michelle A Zandonatti; Debbie D Watry; Lisa J Madden; Steven J Henriksen; Michael A Taffe; Howard S Fox
Journal:  Am J Pathol       Date:  2003-06       Impact factor: 4.307

10.  Hematopoietic origin of microglial and perivascular cells in brain.

Authors:  David C Hess; Takanori Abe; William D Hill; Angeline Martin Studdard; Jo Carothers; Masahiro Masuya; Paul A Fleming; Christopher J Drake; Makio Ogawa
Journal:  Exp Neurol       Date:  2004-04       Impact factor: 5.330

View more
  115 in total

Review 1.  Monocyte mobilization, activation markers, and unique macrophage populations in the brain: observations from SIV infected monkeys are informative with regard to pathogenic mechanisms of HIV infection in humans.

Authors:  Kenneth Williams; Tricia H Burdo
Journal:  J Neuroimmune Pharmacol       Date:  2011-12-14       Impact factor: 4.147

2.  Recently infiltrating MAC387(+) monocytes/macrophages a third macrophage population involved in SIV and HIV encephalitic lesion formation.

Authors:  Caroline Soulas; Cecily Conerly; Woong-Ki Kim; Tricia H Burdo; Xavier Alvarez; Andrew A Lackner; Kenneth C Williams
Journal:  Am J Pathol       Date:  2011-05       Impact factor: 4.307

Review 3.  Heterogeneity of CNS myeloid cells and their roles in neurodegeneration.

Authors:  Marco Prinz; Josef Priller; Sangram S Sisodia; Richard M Ransohoff
Journal:  Nat Neurosci       Date:  2011-09-27       Impact factor: 24.884

4.  Scavenger receptor class B type I (SR-BI) regulates perivascular macrophages and modifies amyloid pathology in an Alzheimer mouse model.

Authors:  Kalliopi Thanopoulou; Apostolia Fragkouli; Fotini Stylianopoulou; Spiros Georgopoulos
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-12       Impact factor: 11.205

Review 5.  Macrophages: An Inflammatory Link Between Angiogenesis and Lymphangiogenesis.

Authors:  Bruce A Corliss; Mohammad S Azimi; Jennifer M Munson; Shayn M Peirce; Walter L Murfee
Journal:  Microcirculation       Date:  2016-02       Impact factor: 2.628

Review 6.  Potential importance of B cells in aging and aging-associated neurodegenerative diseases.

Authors:  Arya Biragyn; Maria Aliseychik; Evgeny Rogaev
Journal:  Semin Immunopathol       Date:  2017-01-12       Impact factor: 9.623

7.  Genetically modified CD34+ hematopoietic stem cells contribute to turnover of brain perivascular macrophages in long-term repopulated primates.

Authors:  Caroline Soulas; Robert E Donahue; Cynthia E Dunbar; Derek A Persons; Xavier Alvarez; Kenneth C Williams
Journal:  Am J Pathol       Date:  2009-04-06       Impact factor: 4.307

8.  Increased monocyte turnover from bone marrow correlates with severity of SIV encephalitis and CD163 levels in plasma.

Authors:  Tricia H Burdo; Caroline Soulas; Krystyna Orzechowski; Jessica Button; Anitha Krishnan; Chie Sugimoto; Xavier Alvarez; Marcelo J Kuroda; Kenneth C Williams
Journal:  PLoS Pathog       Date:  2010-04-15       Impact factor: 6.823

9.  CXCR3-dependent accumulation and activation of perivascular macrophages is necessary for homeostatic arterial remodeling to hemodynamic stresses.

Authors:  Jing Zhou; Paul C Y Tang; Lingfeng Qin; Peter M Gayed; Wei Li; Eleni A Skokos; Themis R Kyriakides; Jordan S Pober; George Tellides
Journal:  J Exp Med       Date:  2010-08-23       Impact factor: 14.307

10.  Coordinated regulation of SIV replication and immune responses in the CNS.

Authors:  Kenneth W Witwer; Lucio Gama; Ming Li; Christopher M Bartizal; Suzanne E Queen; John J Varrone; Angela K Brice; David R Graham; Patrick M Tarwater; Joseph L Mankowski; M Christine Zink; Janice E Clements
Journal:  PLoS One       Date:  2009-12-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.